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Abstract 
Introduction: Visceral leishmaniasis is a serious health problem endemic in 
many regions of Sudan .The outcome of leishmania infection depends on the 
infecting leishmania species and the host immune response .It is known that the 
majority of leishmania infected hosts remain asymptomatic. There is a little 
information available on the seroconversion and the outcome.  
Materials and methods: A longitudinal prospective study was conducted for 12 
months in Dinder National Park in central Sudan. The area is known to be highly 
endemic for VL.Wild Animal Guards in the Park were consented and recruited to 
the study. A total of 110 guards were tested in two surveys for detection of anti 
leishmania antibodies IgG, IgM, IgG1, 1gG2, 1gG3 and IgG4 were measured in 
serum sample collected from the participants using DAT and ELISA. Attempts to 
detect circulating leishmania DNA were done using PCR amplification of 
leishmania kDNA.  Paired sample were obtained from 31 participants.  
 Results: Forty- six guards were IgG positive during the period of the study   
using DAT while eighty-five were positive using ELISA. Two guards had 
antileishmania IgM detected by ELISA. Of the participants who were positive in 
IgG had dominate IgG subclasses Sixteen had IgG1 ELISA, 38 had IgG2 ELISA, 
12 had IgG3 and 3 had IgG4 ELISA  
 Conclusion:The majority of individuals exposed to leishmania infection develop 
asymptomatic infection. The infection induces IgM and IgG antibody responses. 
The role of the induced humoral response in protection and susceptibility against 
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leishmania is not well defined. Further studies needed to investigate the evolution 
of antibody responses in leishmania. 
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Chapter One 
INTRODUCTION AND LITERATURE REVIEW 
1.1. Leishmaniasis: 
 Leishmaniasis is a major vector-borne disease caused by intramacrophage 
protozoa of the genus Leishmania parasites infecting several mammalian species 
including humans. Leishmaniasis is transmitted by the bite of phlebotomine sand 
flies (Bañuls et al, 2007).The disease; leishmaniasis is endemic in areas of the 
tropics, subtropics and southern Europ(Dujardin et al, 2008).   
It is endemic in 88 countries Twelve (12) million people are infected, 350 
millions are considered at high risk of infection and 1.5 to 2 million new cases are 
thought to occur annually (WHO, 2000).  
The geographical distribution of leishmaniasis is limited by the distribution of the 
vector. Ninety percent (90%) of the new Visceral Leishmaniasis (VL) cases occur 
in five countries: Bangladesh, Brazil, India, Nepal and Sudan. Ninety 90% of 
the Mucocutaneous Leishmaniasis (MCL) cases occur in Bolivia, Brazil and Peru, 
while 90% of the Cutaneous Leishmaniasis (CL) cases occur in Afghanistan, 
Brazil, Iran, Peru, Saudi Arabia and Syria (WHO, 2000).  Currently, leishmaniasis 
has a wider geographical distribution pattern than before and it is considered to be 
a growing public health concern for several countries. The increase in 
leishmaniasis’ worldwide incidence is mainly attributed to the increase of several 
risk factors that are clearly man made and include massive migration, 
deforestation, urbanization, immunosuppression, malnutrition and treatment 
failure (Desjeux, 2001). 
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1.2 Clinical forms of Leishmaniasis:  
Leishmaniasis can be classified into four major clinical forms according to the 
severity: cutaneous leishmaniasis (CL), mucocutaneous leishmaniasis (MCL), 
visceral leishmaniasis (VL) and Post-kala-azar dermal leishmaniasis (PKDL) 
(Grimaldi et al; 1993).  
1.2.1 Cutaneous leishmaniasis (CL): 
Cutaneous leishmaniasis (CL) involves ulcerative lesions of the skin, which in 
general are self-limiting. It can be caused by several pathogenic Leishmania 
strains. Cutaneous leishmaniasis (oriental sore) in Sudan is caused by Leishmania 
major zymodeme LON1 (El Safi et al, 1991) and by Leishmania donovani 
(MON-82) (Elamin et al, 2008). Parasite is transmitted by the sandfly vector 
Phlebotomus papatasi (Kirk and Lewis, 1955),  
1.2.2 Mucocutaneous leishmaniasis (MCL): 
Mucocutaneous leishmaniasis (MCL) causes destructive lesions, especially of the 
nasopharyngeal mucosa and cartilages. Ninety percent of all cases of MCL occur 
in Bolivia, Brazil and Peru (WHO, 2000).  In the vast majority of cases it is 
associated with parasites that belong to the Leishmania brasiliensis complex in the 
New World (Grimaldi et al; 1993.). In Sudan Mucosal leishmaniasis (ML) is 
caused by Leishmania donovani, Leishmania major and L.archibaldi (Ghalib et 
al, 1992 Lainson & Shaw et al, 1987, Oskam et al, 1998 ). El Hassan & Zijlstra 
(2001) characterized one isolate from Sudanese ML by isoenzymes and it was 
characterized as L.donovani zymodeme MON-18. 
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1.2.3 Visceral Leishmaniasis (VL): 
Visceral leishmaniasis (VL) is a severe systemic disease characterized by 
involvement of the lymphoid organs and high rates of fatality in symptomatic 
patients. It is generally caused by parasites belonging to the Leishmania donovani 
complex, which are endemic in both the Old World (L. donovani and L. infantum) 
and the New World (L. chagasi) (Grimaldi, et al, 1993). Clinically and 
epidemiologically there are two main forms: (1) zoonotic visceral leishmaniasis 
(ZVL), which affects mainly young children and has the domestic dog as its 
principal reservoir and (2) anthroponotic visceral leishmaniasis (AVL), which 
affects people of all ages, and transmitted from human to human via infectious 
sand fly bites. There are an estimated 0.5 million new cases of visceral 
leishmaniasis per year, concentrated in India, Nepal, Bangladesh, Sudan and 
Brazil, though this is likely to be an underestimate (Bern et al 2008, Reithinger, 
2008).VL is also marked by high levels of leishmania-specific antibodies (Singh 
et al., 1995) which appear soon after infection and before the development of 
cellular immunologic abnormalities, while the antibody titer in kala-azar have 
been exploited for specific diagnosis, their role in resolution of disease and 
protective immunity is largely unknown. It is, however, evident that resistance in 
a large population of individuals residing in areas of endemicity is detectable only 
by the development of specific antibodies and or T-cell response to leishmanial 
antigens (Kurtzhals et al, 1992). 
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1.2.4 Post-kala-azar dermal leishmaniasis (PKDL): 
Post-kala-azar dermal leishmaniasis (PKDL) is a dermal complication of kala-
azar (visceral leishmaniasis). It is characterized by development of macules, 
papules or nodules following treatment of visceral leishmaniasis (El Hassan et al, 
1992). Although it may happen without previous history of VL (Roustan et al, 
1998).All members of L.donovani complex were reported to cause PKDL in 
addition to L.braziliensis in the new world (El Hassan et al, 2001).  
In a prospective study in a village in the endemic area for kala-azar in the Sudan, 
105 of 183 (57%) kala-azar patients developed PKDL. There was a significantly 
higher PKDL rate (69%) in those who received inadequate and irregular treatment 
with antimony (Zijlstra et al, 2000).  
       1.3 Leishmaniasis in the Sudan:  
Leishamaniasis, especially visceral leishmaniasis (VL) is one of the most 
important endemic diseases in the country and is known to occur in the Sudan 
since 1904 when Neave (1904) described the first patient in the country. The main 
endemic area is in the eastern part of the country, from the banks of the White 
Nile in the West to the Ethiopian border in the East. Other smaller foci have also 
been described in parts of Kordofan and Darfur provinces. Occasional severe 
outbreaks occur, like the one in the southern Fung in Blue Nile province in 1956-
1960, which caused thousands of deaths (Sati et al, 1958). An outbreak of kala-
azar was reported in Khartoum among displaced people (de Beer et al, 1990). 
Also, epidemics have occurred in recent years in war zones of southern Sudan 
where about 100,000 people died of leishmaniasis since 1984 (Seaman et al, 
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1996).Transmission dynamics have not been elucidated fully; heavy transmission 
in relatively scarcely populated areas such as Dinder national park suggested 
zoonotic transmission whereas the large numbers of patients with post kala-azar 
dermal leishmaniasis (PKDL) in heavily affected villages may indicate a human 
reservoir and anthroponotic transmission.( El Hassan & Zijlstra., 2001). 
P. orientalis is the only known proven vector of kala-azar in the Sudan 
(Hoogstraal and Heyneman, 1969; Elnaiem et al., 1997). However, in the Kapoeta 
area in South Sudan, where P. orientalis is not known to be present P. martini 
may be the main vector of VL (Miniter et al, 1962). 
1.4 The vectors: 
The vector of various clinical forms of leishmaniasis belong to Order: Diptera; 
Class: Insecta; Family: Psychodidae; and Phylum: Arthopoda.( Kalra and Bang, 
1988). The parasite is transmitted by the bite of infected female sandflies: 
Phlebotomus in the Old World and Lutzomyia in the New World (central and 
south America). Morphologically they resemble very closely with each other. The 
name ‘sand fly’ can be confusing as this name is sometimes used for other species 
as well. Only 10% of the approximately 600 known species of sand flies are 
vectors (Kalra and Bang, 1988) and only 30 of these are known to transmit 
leishmania parasites, these include P.argentipes on the Indian sub-continent, 
P.martini and P.orientalis in Africa and the Mediterranean basin, P.chinensis and 
P.alexandri in china. In the new world Lutzomyia logipalpis is the only known 
vector (WHO, 1991).  
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  leishmania  is transmitted mainly by the blood-sucking females insects, which  
are 2-3 mm long and are found through-out the tropical and temperate parts of the 
world. The sand fly larvae require organic matter, heat and humidity for 
development and so are commonly found in house-hold rubbish, bark of old trees, 
burrows of old trees and in cracks in house walls. (Lewis and Ward, 1987).  
1.5 Reservoir hosts: 
Two cycles of Leishmania transmission were identified. The zoonotic cycle 
include infection of animals’ reservoir while in the anthroponotic cycle patients 
serve as source of parasites. Several animal species were incriminated as 
reservoirs including canine and rodents (WHO, 1991). 
Wild and domesticated animals and humans can act as reservoirs for Leishmania. 
Small mammals serve as reservoirs for several Leishmania species and play a 
major role in the epidemiology of the disease. The importance of rodents in the 
epidemiology of the Leishmaniasis was demonstrated by (Hertig et al, 1957). 
In anthroponotic visceral Leishmaniasis due to L.d.donovani as in India and 
possibly Sudan, man is considered as the principal reservoir host.  In those cases 
asymptomatic carriers and PKDL patients are possible source of infection for 
sandflies (WHO, 1991). 
1.6 Life cycle of Leishmania parasite: 
Leishmania parasites’ life cycle is complex (figure 1). Leishmania has two basic 
life cycle stages: an extracellular stage within the invertebrate host (phlebotomine 
sand fly) promastigotes and an intracellular stage within a vertebrate host 
amastigotes  (Koutis, 2007).  Leishmania life cycle begins when an infected 
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female sand fly takes a blood meal from the vertebrate host. During the blood 
meal intake, the sand fly introduces its mouthparts into the skin tearing tissues and 
the salivary gland content is injected together with Leishmania promastigotes into 
the host’s skin (Titus et al, 1988; Andrade et al, 2007). The promastigotes are 
long, flagellate and extracellular. 
 The promastigotes are then phagocytosed by the host’s macrophages and 
consequently the parasite evolves into amastigote forms –spherical, intracellular 
forms without flagellum that reproduce by binary fission. The multiplication of 
the parasites occurs inside the macrophages, which are their main targets. The 
macrophage lyses and the cycle continue when other hosts’ phagocytes are being 
infected (Bañuls et al., 2007). 
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Figure (1):  The life cycle of leishmania parasites National Institute of Allergy 
and Infectious Diseases (NIAID). (www.niaid.nih.gov). 
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1.7 Diagnosis of the Leishmania infections: 
The diagnosis of Leishmania infections usually relies on direct examination of 
smears from affected tissues or organs after Giemsa staining and in vitro culture 
of clinical samples, i.e., bone marrow, lymph node aspirate or spleen in visceral 
leishmaniasis (VL) and dermal and mucous scrapings, aspirates, or biopsy 
material for cutaneous leishmaniasis (CL) and mucocutaneous leishmaniasis. 
These tools confirm the diagnosis when (i) amastigotes are detected in tissues or 
(ii) promastigotes are obtained in culture, thus allowing species identification by 
enzymatic characterization. However, these methods are time-consuming and 
require culture facilities and individual expertise. Because of these limitations, a 
number of indirect immunological methods, such as enzyme-linked 
immunosorbent assay (ELISA), dipsticks and direct agglutination test (DAT), 
have been developed. Despite the large number of serological tests that are 
available, there is still no gold standard diagnostic test. This is partially due to the 
fact that none of these tests is 100% sensitive and specific (Gangneux et al., 
2003). Moreover, the spread of Leishmania/HIV co- infection complicates the use 
of the serological techniques as a result of low or lack of antibody responses of 
these patients (WHO, 2000). 
Microscopy and culture have the limitations of low sensitivity and are time 
consuming. The immunological methods fail to distinguish between past and 
present infections and are not very reliable in immunocompromised patients. 
While the molecular approach is capable of detecting nucleic acids unique to the 
parasite, and would address these limitations. A variety of nucleic acid detection 
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methods targeting both DNA and RNA have been developed. Amongst these, the 
PCR has proved to be a highly sensitive and specific technique. The PCR assays 
can detect parasite DNA or RNA a few weeks ahead of appearance of any clinical 
signs or symptoms. Different DNA sequences in the genome of leishmania like 
ITS region, gp63 locus, telomeric sequences, sequence targets in rRNA genes 
such as 18s rRNA and SSU-rRNA and both conserved and variable regions in 
kinetoplast DNA (kDNA) minicircles are being used by various workers. (Attar   
et al, 2001 ; Santos-Gomes  et al, 2000 ; El Tai   et al, 2001 ; Pizzuto  et al, 2001, 
and Wortman et al, 2001). 
1.7.1 Parasitological diagnosis: 
1.7.1.1 Microscopy:  
The commonly used method for diagnosis of leishmaniasis is the demonstration 
of parasites in spleenic or bone marrow aspirate. Lymph nodes aspirates, liver 
biopsy or, the buffy coat of peripheral blood (in case of VL), or aspirate 
specimens (in case of CL & PKDL) stained with Giemsa stain (Sundar and   Rai, 
2002). 
Different diagnostic methods were evaluated in the Sudan and variable 
sensitivities were observed, lymph node aspirates had a sensitivity of 53-58%, 
bone marrow aspirates had sensitivity 53-70% as reported in two studies in Sudan 
(Zijlstra et al, 1992), and spleen aspiration reached a sensitivity of 95-97% (El 
Hassan et al, 2001). In contrast, smears of skin biopsy material from PKDL 
patients showed sensitivity of only 30 % (Osman et al, 1997) while examination 
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of paraffin embedded skin biopsies from PKDL patients revealed Leishmania 
parasites in 20% of tested samples (Ismail et al, 1997). 
1.7.1.2 Culture of leishmania parasites:  
 Culture of parasite can improve the sensitivity of detection of the parasite; 
Leishmania strains can be maintained as promastigotes in artificial culture 
medium. Bone marrow, spleenic or lymph node aspirates for VL patients and skin 
biopsies for PKDL and CL patients could be inoculated into culture media for 
isolation and typing of the parasite. The used culture media include monophasic 
(Schneider’s insect medium, M199, or Grace’s medium) or diphasic (Novy-
McNeal Nicolle medium and Tobies medium) .The parasite can also be 
demonstrated after inoculation of laboratory animals (such as hamsters, mice or 
guinea pigs) with infected specimen ( Sundar and M. Rai, 2002). 
1.7.2 Leishmanain Skin test: 
The Montenegro skin test (leishmanin skin test) tests the delayed hyper sensitivity 
(DTH) specific to leishmaniasis. In this method, 0.5 ml of phenol-killed whole 
parasites (5 -107 promastigotes) is injected on the volar aspect of the forearm of 
the patient. After 48 to 72 h, the size of induration is measured and compared with 
the size of induration produced by injection of a phenol-saline control in the other 
forearm (Sundar and Rai, 2002). 
The test could be positive during CL infection and is useful for follow-up in 
vaccination programs (da Costa et al, 1996). Results of the Montenegro test in 
acute VL infection are always negative. 
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1.7.3 Serological diagnosis:  
1.7.3.1 Antibody detection:  
1.7.3.1.1 Enzyme linked immunosorbant assay (ELISA): 
 ELISA has been used as a potential serodiagnostic tool for almost all infectious 
diseases, including leishmaniasis. The technique is highly sensitive, but its 
specificity depends upon the antigen used. Several antigens have been tried. 
(Whole promastigote and promastigote lysate) The commonly used antigen is a 
crude soluble antigen (CSA). The sensitivity of ELISA using these concentrations 
of CSA is reported to range from 80% to 100%, but cross-reactions with sera 
from patients with trypanosomiasis, tuberculosis, and toxoplasmosis were 
reported (Bray et al, 1976; Bray et al, 1985). 
1.7.3.1.2   rK 39:  
The recombinant antigen, rK39, has been shown to be specific in detecting 
antibodies in patients with VL. It is highly sensitive and predictive of the onset of 
acute disease. The antigen is derived from L. chagasi (Alborzi et al, 2006). 
1.7.3.1.3 Direct agglutination test (DAT):  
The direct agglutination test is a simple, fast and economic technique that was 
described by Allian and Kagan (1975) and modified by ElHarith et al (1986) for 
the diagnosis of visceral leishmaniasis. 
In this test, the trypsinized whole promastigotes are formalin fixed and stained 
with Coomasie brilliant blue; serum from the patient is then incubated with the 
antigen, and agglutination is observed the next day. Use of a 0.8% concentration 
of 0.1 M 2-mercaptoethanol in the sample diluent further improves its 
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performance. DAT in various studies has shown to be 91% to 100% sensitive and 
72% to 100% specific (Badaro, 1996). 
Freeze-dried antigens developed in Belgian and Dutch laboratories are likely to 
overcome some problems like difficult field conditions, the fragility of aqueous 
antigen, the lack of cold chain, and batch to batch variations in the antigen 
(Mengistu, 1990). 
1.7.3.1.4 Indirect immuno fluorescent antibody test (IFAT): 
The IFAT is one of the most sensitive tests available for diagnosis of VL. It is 
based on detecting antibodies in very early stages of the infection (Williams, 
1995). The higher sensitivity of the amastigote-based IFAT resulted in an earlier 
diagnosis in the absence of clinical signs (Fernandez-Perez et al, 1999). Nigro et 
al (1996) found that the results of IFAT and DAT had similar specificity but 
IFAT had a higher sensitivity and a greater diagnostic significance. 
1.7.3.2 Antigen detection: 
 1.7.3.2.1 Latex agglutination: 
Latex agglutination test (KATEX) was developed for detecting leishmanial 
antigen in urine of patients with VL. It has sensitivity between 68 %and 100% 
and a specificity of 100% in preliminary trials (Attar, 2001). The antigen is 
detected quite early during the infection and the results of animal experiments 
suggest that the amount of detectable antigen tends to decline rapidly following 
chemotherapy (Attar, 2001). 
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1.7.3.2.2 Immunoblotting: 
It was found that sera from visceral leishmaniasis patients recognized numerous 
antigens with molecular weights ranging from 14-110 kDa (Salotra et al, 1999).  
Studies with four clinical isolates of L. donovani showed that the 70 kDa protein 
was expressed in all examined strains 
1.7.4 Molecular diagnosis:  
Due to the limitations inherited in the techniques used for detection of parasites, 
new approaches for detection of parasites, such as DNA hybridization, have been 
attempted since the early 1980s. Although these methods had considerable 
sensitivity (detecting as few as 50 to 100 parasites) (Lanotte, 1981), their potential 
use in routine diagnosis is hampered by the complex procedure of hybridization. 
The development of PCR has provided a powerful approach to the application of 
molecular biology techniques for diagnosis of leishmaniasis. Primers designed to 
amplify conserved sequences found in minicircles of kDNA of leishmanias of 
different species were tested in various tissues of relevance (Sundar and Rai, 
2002). 
1.8 Immunity to leishmaniasis: 
Macrophages play a primary role in the host defense and regulation of immune 
responses upon activation (Unanue and Allen, 1987). The parasites perform a 
complex host-parasite interaction inside the severe environment of the 
phagolysosomes and eventually evade this immune defense mechanism 
(Alexander, 1992). 
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Although most of the informations on the immunologic mechanisms upon 
infection and protection from the Leishmania parasites were accumulated from 
the studies in mice. However, the immune response due to VL and the 
pathogenesis of the disease in human deviates considerably from the murine 
model. 
Resolution of leishmanial infections requires the expansion of specific type I T 
helper cells (Th I) that secrete or express on their membrane lymphokines capable 
of activating macrophages that contain these parasites to a microbicidal state. 
Specific CD8+ T cells, which are triggered during infection, also appear to play a 
role in protective immunity, possibly through their ability to secrete interferon-
gamma. In the mouse model of infection with Leishmania major, the expansion of 
specific type II T helper cells exacerbates disease, an effect that result from the 
properties of type II T helper derived lymphokines to deactivate macrophages and 
inhibit release of activating cytokines by type I T helper cells. In the mouse, 
destruction of intracellular Leishmania by activated macrophages depends upon 
the L-arginine-dependent production of nitric oxide. Molecules from the parasite 
that can induce, and are the target of, the protective T-cell response have been 
characterized (Locksley, 1991). 
Enhanced induction of IL-10 and IL-4 mRNA in tissues and elevated levels of IL-
4, IL-10, and IgE over IFN-g  in serum (Ghalib et al, 1993) suggested that a 
dominant Th2 response suppresses the activity of Th1 during disease. 
With successful drug therapy, T-cell proliferation and IL-2 and IFN-g  production 
in response to leishmania antigen are restored. Cured individuals, however, show 
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leishmania-reactive T cells with Th1 and Th2-type lymphokines coexisting after 
infection (Kemp et al, 1993). Thus, the heterogeneous set of cytokine responses 
provoked by kala-azer during disease and resolution of infection reflects a 
complex Th1-Th2 cell picture that is difficult to delineate for indicators of clinical 
improvement. 
1.8.1. Humoral Immune response in leishmanaisis: 
Infection of Leishmania in human is characterized by the appearance of anti-
leishmanial antibodies in the sera of the patients. In CL, usually they are present 
at low levels during the active phase of the disease ( Behin , 1989 ) .  However, in 
some studies the presence of antibodies against L. braziliensis infection in the sera 
of infected patients has been critically monitored and utilized for the diagnosis 
and prognosis of the disease (Montoya, 1997; Romero, 2005). Contrastingly, 
strong anti-leishmanial antibody titres are well documented in VL (Bray, 1976; 
Neogy, 1987). 
Although it is known that the Th1 cytokine interferon-gamma (IFN-g  ) probably 
upregulates isotypes IgG1 and IgG3, and the Th2 cytokines IL-4 and IL-5 
stimulates the production of IgG4 in human  (Abbas et al ,  1996 ; Rothman et al , 
1996 ).   The role of the elevated anti-leishmanial antibodies in kala-azar patients 
towards protection or pathogenesis is still unclear. 
Hailu  et al , (2001 )  attempted to utilize the relative abundances of the anti-
leishmanial IgG subclasses to discriminate among the immunity of the active and 
cured patients as well as the endemic healthy individuals and showed that a low 
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cell mediated immunity ( CMI ), in terms of delayed type hypersensitivity (DTH) 
is correlated with high IgG1, IgG3 and IgG4 and vice versa. 
 As it is still debatable whether these antibodies have any role in the protection of 
the disease, a recent experimental study postulated that IgG not only fails to 
provide protection against this intracellular pathogen, but it actually contributes to 
disease progression. Passive administration of anti-leishmanial IgG resulted in 
larger lesions in BALB/c mice with greater amount of IL-10 production (Miles et 
al, 2005). This result can be correlated with the highly elevated titres of anti-
leishmanial antibodies during the active phase of the disease and a consecutive 
fall in the antibody titre after a successful cure. In addition, studies have shown 
that large CL lesions were correlated with a higher frequency of lymphocytes 
producing leishmania soluble antigen specific inflammatory cytokines (IFN-c or 
TNF-a) (Antonelli et al, 2005). 
Analysis of leishmania antigen -specific immunoglobulin isotypes and IgG 
subclasses in VL patient sera revealed elevated levels of IgG, IgM, IgE and IgG 
subclasses during disease (Atta et al., 1998; da Matta et al., 2000 and Ravindran 
et al., 2004).  
Anam et al, (1999) investigated the levels of immunoglobulin subclasses in Indian 
Kala-azar patient sera during disease, drug resistance, and cure. Acute-phase sera 
showed strong stimulation of IgG, followed by IgE and IgM and lastly by IgA 
antibodies with expression of all of the IgG subclasses, with a predominance of 
IgG1 during disease. Furthermore drug resistance was associated with a reduction 
in IgG2 and IgG3 antibodies, with no significant change in titers of IgG, IgM, 
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IgA, IgE, and IgG4. A successful cure corresponded with a decline, most 
significantly, in the levels of IgE, IgG4, and IgG1. 
The natural course of humoral immunity in VL could provide valuable data that 
could be used for improvement of diagnosis, prognosis, and management of VL. 
1.8.2 Cell Mediated Immune response in leishmaniasis:  
Despite the differences between CL and VL, resistance to disease in both the 
forms of leishmaniasis is marked by a dominant Th1 response. Severe 
manifestation of CL is associated with a strong Th2 compared to a predominant 
Th1 response in the mild manifestation of the disease (Gaafar et al, 1995) On the 
other hand, it is well documented that VL is characterized by suppression of CMI, 
which is proved from the unresponsiveness of the patients to the Leishmanin Skin 
Test (LST) or Montenegro test (Manson-Bahr, 1961). 
Containment of the disease following a successful treatment is associated with a 
strong cell mediated Delayed Type Hypersensitivity (DTH) response (Reiner, 
1995). 
The two functionally distinct CD4+ T cell subsets, T helper 1 (Th1) and T helper 2 
(Th2), are distinguishable by the pattern of cytokines they produce upon 
stimulation (Mosmann and Coffman, 1989).  
Th1 cells are characterized by secretion of IFN-g and lymphotoxin that are known 
to activate host defences against intracellular pathogens, while Th2 cells produce 
IL-4, IL-5, and IL-13 (Cherwinski et al, 1987) that favour the development of 
humoral responses against extracellular pathogens and also has antagonize the 
action of IFN-g  and suppress macrophage activation , therefore Th2 may function 
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as physiologic regulators of immune responses by inhibiting potentially injurious 
action mediated by Th1 responses (Abbas et al, 1996). 
Activation of macrophages to a parasiticidal state by IFN-g  is the main anti-
Leishmania effector mechanism. Indeed, IFN-g has been demonstrated to increase 
the synthesis of inducible nitric oxide synthase (iNOs) leading to the L-arginine 
dependent production of reactive nitrogen radicals toxic for the parasite (Assreuy 
et al, 1994). IFN-g  which in turn acts on macrophage to induce IL-12 secretion 
which binds to naïve CD4+ T cells and promotes their differentiation to Th1 cells.  
The role of IFN-g in conferring resistance to infection with L. major was 
demonstrated by showing that genetically resistant mice lacking either the IFN-g 
or the IFN-g receptor gene are unable to control parasite growth (Swihart et al, 
1995). The IFN-g mediated activation of macrophages can be regulated by other 
cytokines produced by Th2 cells such as IL-4 and IL-10 (Liew et al, 1989). 
Th1 and Th2 CD4 T cells develop from common naive CD4 T cell precursors 
(Kamogawa et al, 1993). Several parameters have been reported to influence the 
pathway of differentiation of CD4 T cell precursors, including the type of antigen 
presenting cells (Moser and Murphy, 2000), the nature of the costimulatory 
signals (Kuchroo et al., 1995), the extent of T cell receptor (TCR) engagement 
(Pfeiffer et al., 1995), the dose of antigen (Hosken et al., 1995), the route of 
antigen administration (Gue´ry et al, 1996), and the number of cell division (Bird  
et al., 1998). Among these different T cell polarising signals and cytokines have 
been recognized as crucial inducers of CD4 Th1 and Th2 cell differentiation.  
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1.10 Treatment of leishmaniasis: 
Pentavalent antimony compounds (Sb), were first used for treatment of 
leishmaniasis in the early 1900s and continued to be the drugs of choice for 
cutaneous and visceral disease.  The most widely used pentavalent antimonial 
agents used today are sodium stibogluconate (Wellcome Foundation, United 
Kingdom) and meglumine antimoniate (Rhône Poulenc,France)(Berman et al., 
1988).  The sodium stibogluconate dose is 20-mg/kg body weight/day, while the 
duration varies from one endemic area to another, partly reflecting variability in 
parasite sensitivity.  The reported treatments were: 4 weeks in Kenya (Anabwani 
et al., 1983), 15-30 days in Sudan (Zijlstra et al., 1993; Seaman et al., 1996) and 
40 days in India (Thakur et al., 1988).  Currently, WHO recommends a dose of 20 
mg / kg body weight/day for 4 weeks (WHO, 1990). A longer or shorter course of 
treatment may be necessary depending on the situation, but one must be aware 
that longer courses can increase the risk of drug-related toxicity, while shorter 
courses may risk a relapse or poor response.   
1.10 Leishmaniasis control: 
Improved control reduces both mortality and morbidity. It also reduces the role of 
humans as a reservoir in anthroponotic cycles and makes it possible to avert 
progression of the disease to complicated cutaneous forms. The combination of 
active case detection and treatment is the key to control. Nevertheless, even that 
seemingly simple approach faces major obstacles. Although during their initial 
phases, leishmaniases respond well to treatment, many patients are unaware of the 
initial symptoms. Furthermore, health systems are frequently either poorly staffed 
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and lack equipment or are non-existent in remote rural areas where contact with 
sandflies is most common.(WHO,2006). 
Spraying houses with insecticide is the most widely used intervention for 
controlling sandflies that are endophilic (rest mostly indoors after feeding). House 
spraying with the pyrethroid lambdacyhalothrin reduced the risk of cutaneous 
leishmaniasis, (Reyburn, et al., 2000) sandflies are endophagic (mainly feed 
indoors) and most active when people are asleep, bed nets provide considerable 
protection.  For example, a case-control study in Nepal showed that people using 
untreated nets were 70% less likely to develop visceral leishmaniasis than people 
without nets. (Bern et al, 2000). 
In the absence of a reliable and rapid tool for detecting infected dogs, alternative 
control strategies for zoonotic visceral leishmaniasis are being sought. Dipping 
dogs in insecticide or applying topical insecticide lotions can substantially reduce 
sandfly bites on dogs and so protect them from infection, but this strategy requires 
regular retreatment as the insecticidal effect is short lived (Reithinger et al, 2001). 
1.10.1 Vaccine: 
Of all the parasitic diseases, leishmaniasis is considered the most likely to 
succumb to vaccination. The parasite has a particularly simple life cycle, 
resolution of primary cutaneous leishmaniasis usually results in resistance to re-
infection, and studies in experimental models have suggested simple CD4 Th1-
type, cell mediated resistance (involving activation of macrophage killing 
mechanisms by T lymphocyte-derived interferon ? ). In experimental models of 
cutaneous leishmaniasis, in which CD4 Th1 responses are driven towards a 
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polarised Th1 response, protection can indeed be achieved by vaccination, 
although this rarely results in complete protection from development of lesions. 
Such vaccines, however, stimulate only poor memory, and protection wanes after 
a few weeks.( Handman,2001) In primate studies and clinical trials they show 
immunogenicity but rarely give appreciable protection.( Kenney et al,1999), 
(Belkaid et al, 2002). 
Rationale: 
Visceral leishmaniasis patients present a strong humoral response to Leishmania 
infection. The induced anti leishmania antibodies directly correlates with the 
severity of the disease and inversely related to cure and protection. The current 
diagnosis methods of VL are based on detection of anti- Leishmania antibodies in 
serum of suspected patients and demonstration of the parasite in lymph nodes, 
spleen or bone marrow aspirates. Patients usually reports for diagnosis after the 
development of the clinical symptoms and no data is available about the time of 
infection or incubation period. Furthermore, the course of the induced antibodies 
during treatment and after cure is not known. Monitoring of the antibody 
evolution of VL could provide valuable data that can improves the diagnosis, 
predict the prognosis and improve the management of VL patients. 
General objectives: 
To improve the diagnosis and management of Visceral Leishmaniasis through 
monitoring the evolution of the humoral immune response of healthy individuals 
living in visceral leishmanasis endemic area in Dinder National Park in central 
Sudan.  
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Specific objectives: 
1- To monitor the seroconversion of individuals living in VL endemic area. 
2- To monitor the course of sero reactivity and development of clinical disease. 
3- To detect the leishmania parasite DNA in blood of individuals living in VL 
endemic area.    
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Chapter Two 
MATERIALS AND METHODS 
2.1 Study area and population: 
This study was conducted in Dindir National Park in central Sudan. The park is 
wild animal reserve and known to be hyperendemic of visceral leishmaniasis. The 
Park is known to be highly endemic of zoonotic Visceral Leishmaniasis, due to 
the large number of animals that can act as reservoir hosts for the diseases, while 
sandflies are the vectors of parasites .The study was approved by the research 
ethics committee of the Institute of Endemic Diseases, University of Khartoum. 
All particibants were recruited according to their residence in the park. 
 One hundred and ten (110) wild animal guards working in Dindier National Park 
were consented and recruited to the study. Most of them are working inside the 
Park. Every participant was screened for exposure to Leishmania infection by 
clinical examination, detection of anti Leishmania antibodies using the DAT test 
and ELISA. The participants were followed for 12 months by visits the campus. 
In each visit the participants were physically examined and screened for 
Leishmania antibodies using DAT. The induced antibody titers and 
immunoglobulin classes and subclasses were measured using ELISA. PCR was 
used to detect Leishmania parasite kDNA in the samples. 
2.2 Study design: 
A longitudinal prospective study was conducted for 12 months. 
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2.3. Sampling method: 
Samples were taken from wild animal guards, male and females (figure 2) aged 
20-60 years throughout the two surveys, which were carried out in June 2009 and 
June 2010. 
1.  First trip was Started with a sample size of 51; female [5], male [46].  
2. Second trip sample size of 59; female [4], male [55].  
3. There were thirty-one samples collected twice in both surveys. 
2.4 Study subjects: 
One hundred and eleven (110) new appointed and continue working guards were 
consented and recruited to the study in the two surveys. 
2.5 Recruitment of participants: 
The participants were recruited according to their residence in the park. 
2.6 Ethical clearance: 
This study was approved by the research committee of the Institute of Endemic 
Diseases, University of Khartoum. Informed verbal consent was obtained from 
the wild animal guards department. 
2.7 Inclusion criteria: 
1. Adults, age 20 to 60 years.  
2. Healthy with no serious health problem. 
2.8 Methods of data collection and sample: 
Data was collected via:  
1. Questionnaire filled by personal interviews. 
2. Blood was collected on Whatman No.3 filter papers. 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
26 
 
2.9 Diagnosis of VL: 
2.9.1 Physical examination: 
Medical examination of the participants was done by qualified medical doctor. 
The body temperature, the size of lymph nodes, spleen, and liver were recorded. 
2.9.2 Elution of blood sample from filter paper: 
Circles of 1cm diameter were bunched from Whatman No.3 by paper punch. 
Filter papers soaked in donor blood (equivalent to 5 µl blood).  The punched 
papers were inserted in 1.5  ml eppendorf tubes and incubated with 125 µl 
normal saline for 18 hours. The eluted sera (from the filter paper) were serially 
diluted into the V-shape wells of microtitre plate.  
2.9.3 Direct agglutination test (DAT): 
DAT was carried out as described by El Harith et al, (1986) in V-shaped 96 well 
microtiter plates. Serum samples were serially diluted (1:100 to 1:6553600) in 
0.2% gelatin containing 0.9% NaCl (w/v) and 0.78% (v/v) 2-mercaptoethanol. 1=  
3200 serum dilutions used as the cut off positive sample. 
2.9.3.1 Performance of the DAT:  
Fifty µl of serum diluents (0.9% NaCl, 0.2 % Gelatin and 0.8% 2ME) were 
dispensed into the V-shape wells of microtitre plate; rows 1 and 3-12 (A-H). 75 µl 
of the diluent was dispensed into row 2 (A-H), and then 25µl of eluted sera (test 
and control samples) was added in row 2(A-H). After mixing with multi channel 
micro pipette, 50µl was transferred to row 3. This was repeated until row 12; from 
which 50 µl were discarded. 50µl of the antigen were added in all wells. The plate 
was gently tapped on all sides in order to mix the content and incubated for 18 
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hours at room temperature. Serial dilution of the samples starting from 1:100 to 
1:102400 were achieved. The agglutination activity was determined visually and 
the titer of the reaction was recorded for each sample. 
2.9.3.2 Interpretation of DAT results:  
A cut off titer = 1:3200 was considered as a positive result 
2.9.4 ELISA for parasite-specific Igs: 
Enzyme-linked Immunosorbant assay (ELISA) was done to measure IgG, IgM,   
and IgG subclass antibodies to Leishmania in collected serum samples. The test 
was carried out on polystyrene round-bottom microtiter plates (Tarsons). Antigen 
extracted from L.donovani was applied to the plates at 20 mg/ml in 0.02 M 
phosphate buffer (PH 7.5) and incubated at 40C overnight. Following 3x washes 
the plates with PBS supplemented with 0.05% Tween 20, excess reactive sites 
were blocked with 2% gelatin for 1h at room temperature, washed as before, and 
subsequently incubated overnight at 2h at room temperature with kala-azar sera 
serially diluted in PBS containing 1% gelatin. After washing, peroxidase-
conjugated goat polyclonal antibodies directed against human IgG and IgM 
(Sigma immunochemical, St. Louis,Mo.) were applied at a 1: 5,000 dilution in 
PBS for 3 h at room temperature. 
After four washes, o-phenylenediamine dihydrochloride were added as an enzyme 
substrate for 45 min, and the optical density was read at 450 nm in ELISA reader 
(Thermal Labsystem- Multi Ascent model NO 354). 
For the determination of human IgG subclass antibodies, the washed wells were 
incubated with serially diluted. Kala-azar sera were probed with mouse anti 
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human IgG subclass-restricted monoclonal antibodies (sigma immunochemical) at 
a 1:3,000. 
Dilution for 3 h at room temperature. After three washes, peroxidase-conjugated 
goat anti-human IgG (sigma immunochemicals) was applied at 1:5,000 dilution 
overnight at 40C. The color reaction was carried out as described above, and the 
optical density was read at 450 nm. Titers were determined from the extensive 
titration of each serum sample as dilution of serum required to reach half-maximal 
absorbance.   
2.9.5 DNA extraction: 
Two methods of DNA extraction were used to detect subclinical infection. 
2.9.5.1 Phenol chloroform method: 
Using sterile puncture, 2 pieces from the blood drops of filter paper were placed 
in sterile labeled eppendorf tube and then 245 ul  lysis buffer was added . 2.5 ul of 
Triton X-100 were added. 2.5 ul of proteinase K then were added and incubated at 
60 0 C overnight. 
In the next day an equal volume ( 250 ul ) of buffered phenol were added and 
shaked gently for at least 2 minutes and centrifuged at maximum speed for 2 
minutes ,   the aqueous phase were transferred to a clean labeled tube and the 
organic phase were discarded . An equal volume of chlorophorm - phenol mixture 
(phenol: chlorophorm, 1:1 v / v) were added and centrifuged as in the last step.  
Then an equal volume of chloroform were added and centrifuged as before.    
The DNA were precipitated by adding double volume of cold absolute ethanol 
and mixed gently and incubated overnight at –20 0 C. 
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On the third day the samples were thawed and centrifuged at maximum speed 
4000 rpm for 20 minutes. The supernatant were discarded and the tubes were 
filled half away with 70 % ethanol and centrifuged at 12000 rpm for 15 minutes, 
this step was done twice. 
 The tubes were kept on the bench at room temperature until the last traces of 
fluid evaporated .Then the DNA pallet (which is often invisible) were dissolved in 
DW. The DNA was then stored at -20 o C until used. 
2.9.5.2 Chleix method: 
100 ul of a 5 %( w/v) Chelex-100 solution (sigma) were added to 1.5 ml 
microcentrifuge tube and placed in heating block at 1000 C for 5 minutes. A circle 
of 1cm diameter was bunched from whatman No.3 filter papers soaked in donor 
blood (equivalent to 5 µl blood). The filter papers were then immersed in   the hot 
chelix solution.  The tube was capped, gently shaken for 30 seconds, and then 
returned to the heat block for 10 minutes.  The samples were centrifuged at 
12.000 rpm for 2 minutes and the supernatant was removed to a new 
microcentrifuge tube and spun again at 12.000 rpm for 2 minutes.  The 
supernatant was removed to a new microcentrifuge tube and either used 
immediately in amplification reaction or stored at -200C until used.  
2.9.6 PCR: 
kDNA PCR was done as described by Smyth et al (1992) using genus specific 
primers for mini-circle kinetoplast (kDNA) the AJS3  
5'ggggTTggTgTAAAATAgggC-3' and DBY 5'CCAGTTTCCCgCCCCggAg-3’ 
primers.  The reaction volume was 50 ul per sample in 0.5 ml thin walled micro 
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centrifuge tube. The mixture consisted of 5ul of 10x reaction buffer, 2ul of 20mM 
dNTP mix (ABgene-0196-UK), 3ul of 25mM MgCl2 to a final concentration of 
1.5ul.2.0ul of primer mixture (10mM each), to a final concentration of 0.5uM 
each and 0.25ul of thermo-stable DNA polymerase (5U/ul). For each PCR tube 
3ul of template DNA were added; PCR mixture was then completed to 50ul with 
double distilled water. PCR was done using Perkin Elmer thermal cycler (480-
USA) .The amplification was done for 35 cycles. The DNA was initially 
denatured at 940C for 3min. Each cycle included annealing at 670C for 1min, 
extension at 720C for 1min and denaturation at 940C for 30sec. A final extension 
cycle at 720C for 10 min was run.   The PCR products were stored at 40C until 
analyzed. 
2.9.7 Gel electrophoresis:  
90 ml distilled water and 10 ml 10X Tris boric EDTA (TBE) were added to 1.0 
gram of agarose. The mixtures were melted and 3ul of Ethidium Bromide 
(10mg/ml) were added to the gel and mixed, the mixture was then poured into 
horizontal electrophoresis tank and the gel was left to polymerize. 7µl of PCR 
product were mixed with loading buffer and loaded into the gel .10µl of DNA 
molecular weight marker was also loaded. Running buffer was added containing 
95ml distilled water and 5 ml 10x TBE buffer. The run were performed at 80 Volt 
and the current range was from 3-8 mA for 30 minutes. The gel was then 
visualized over ultra violet transilluminator (UVP) and photographed.    
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2.10 Data analysis: 
The data were entered, verified and analyzed using SPSS version18 and Sigma 
Plot version11. 
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Chapter Three 
RESULTS 
3.1. Study Participants: 
Two surveys were conducted in June 2009 and June 2010.    
Fifty one wild animal guards with previous VL history or not (figure 3) were 
recruited during the first trip and fifty nine were recruited during the second 
survey. Thirty one participants were sampled during the two surveys. The age 
range of the participants ranged between 20 – 60 years.   
3.2.1 Direct agglutination test (DAT) results: 
In the first survey the number of positive reactors (DAT titer =  1:3200) were 
22(43.1%) out of 51. 
While the number of positive reactors in the second survey were 24(26.6%)   
participants out of 90.Twenty guards were missed in the second survey and only 
31 were sampled twice. Fifty nine (59) new guards were sampled in the second 
survey.  
 Of the thirty-one (31) cohort sampled in two surveys, the number of positive 
DAT reactors in the first survey were 12 ;( 38.7%) participants, 4 (19.35%) 
converted to negative during the second survey.    
3.3. Enzyme-linked immunosorbent assay (ELISA) results: 
3.3.1 Enzyme-linked immunosorbent assay (ELISA) results for IgG: 
In the first survey 28 ;( 54.9%) participants were positive in IgG ELISA, while 57 
(63.3%) were positive in the second survey. 
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3.3.1.1 Conversion of ELISA for IgG result: 
Of the thirty-one (31) cohort. 19 ;( 61.3%) participants were positive IgG ELISA 
in the first survey. 6 ;( 19.35%) were reactive in the first survey and converted to 
negative in the second survey. Nine 9 ;( 29%) were non reactive in first survey 
and converted to positive in second survey. While 11 (35.5%) were reactive 
positively in IgG ELISA in both surveys.  
3.3.2 Enzyme-linked immunosorbent assay (ELISA) results of IgM: 
All sample tested negative for anti-leishmania IgM in the first survey, 2 (2.2%) 
were   reactive in the second survey. 
3.3.3 Enzyme-linked immunosorbent assay (ELISA) results of IgG1: 
Samples were had no anti-leishmania IgG1 during the first survey,while in the 
second survey 16 (17.8%) samples were reactive. 
 3.3.3.1Conversion of ELISA for IgG1 results: 
Of the 31 participants were negative in IgG1 ELISA in the first survey. In the 
second survey 7 ;( 22.6%) were reactive positively in IgG1 ELISA. 
3.3.4 Enzyme-linked immunosorbent assay (ELISA) results for IgG2: 
ELISA for IgG2 was not done for the sample collected during the first survey. 
While in the second survey 38 (42.2%) participants were reactive positively in 
IgG2 ELISA.  
3.3.4.1Conversion of ELISA for IgG2 result:  
Of the 31 participants in the second trip 14 (45.2%) were reactive for 
antileishmania IgG2.  
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3.3.5 Enzyme-linked immunosorbent assay (ELISA) results for IgG3: 
Samples were negative for IgG3 in the first survey, and 12 (13.3%) were reactive 
for IgG3.    
3.3.5.1Conversion of ELISA for IgG3 result: 
None of the 31 cohort members was reactive for IgG3 during the first survey.  
3 (9.7%) were reactive positive for IgG3 in the second survey. 
3.3.6 Enzyme-linked immunosorbent assay (ELISA) results for IgG4: 
None of the samples were IgG4 reactive during the first survey, 3 (3.3%) 
converted to positive during the second survey.   
3.3.6.1Conversion of ELISA for IgG4 result:  
All members of the cohort were none reactive in the first survey, while 2 (6.5%) 
were converted to positive in the second survey. 
3.4. Polymerase chain reaction (PCR) result: 
None of the samples had detectable parasite DNA. 
ϵ%
ϵϭ%
Female 
Male 
 
Figure 2. Gender distribution of the participates. 
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Figure 3. Previous visceral leishmaniasis cases among participants. 
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Figure 4. Detection of anti -Leishmania antibodies in sera of the participants of 
the first survey using ELISA. 
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Figure 5. Detection of anti- Leishmania antibodies in sera of the participants of 
the second survey using ELISA. 
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  Figure 6. Detection of anti -Leishmania IgG subclasses in some of participants   
of the second survey using ELISA. 
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Table 1. Anti -Leishmania antibodie titre as detected by direct agglutination test 
(DAT) of 31 individuals in the first trip and the same 31 individuals in the second 
trip. 
 
 
DAT 
 
1/1600 or less 
 
1/3200 
 
1/6400 
 
     1/12800 
Trip NO % NO % NO % NO % 
1st  
survey 
19 61.3 % 5 16.1 % 
 
5 16.1% 2 6.5% 
2nd 
survey 
23 74.2% 6 19.4 % 
 
1 3.2% 1 3.2% 
 
Table 2. Results of 31 participants in first and second survey for IgG total, IgM, 
IgG1, IgG2, IgG3 and IgG4 using ELISA. 
 
 
 
survey 
 
 
ELISA 
 
 
IgG 
 
.IgM 
 
IgG1 
 
IgG2 
 
IgG3 
 
IgG4 
NO % NO % NO % NO % NO % NO % 
 
1st 
survey 
+ve 
 
 -ve 
 
19 
 
12 
61.3% 
 
38.7% 
0 
 
31 
0 % 
 
100% 
0 
 
31 
0% 
 
100% 
N.D 
 
N.D 
N.D 
 
N.D 
0 
 
31 
0% 
 
100% 
0 
 
31 
0% 
 
100% 
 
2nd 
survey 
+ve 
 
 -ve 
 
20 
 
11 
64.5% 
 
35.5% 
1 
 
30 
3.2 % 
 
96.8% 
7 
 
24 
22.6% 
 
77.4% 
14 
 
17 
45.2% 
 
54.8% 
3 
 
28 
9.7 % 
 
90.3% 
2 
 
29 
6.5% 
 
93.5% 
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Chapter Four 
DISCUSSION 
 
The outcome of infection by Leishmania parasites depends on the infecting 
parasite species and the host immune response to the infection. The majority of 
individuals infected with Leishmania remain asymptomatic. Little data is 
available on the natural course of infection. This study aimed to determine the rate 
of asymptomatic infection among individual living in endemic area. The study 
was conducted in Dindir National Park. Two cross sectional survey were 
conducted in June 2009 and June 2010. The park guards were recruited for 
monitoring their antibody responses to leishmania as indicator of exposure to 
infection, serum samples were collected for measuring antibodies and for 
detection of  leishmania DNA using PCR. The rate of DAT seroreactivity of the 
participants was 38.7% in the first survey and 25.8% in the second survey 
indicating active transmission of leishmaniasis during the study period .in another 
study conducted in village at Attbara River reported by El-Safi et al (2002) the 
positive DAT rate was 5%. A similar study conducted in India by Gidwani et al 
(2009) a DAT rate ranged between 10%-26%. The differences in DAT rates could 
be due to the variation in transmission of infection. The site were this study was 
conducted is known to be with in high transmission area. An interesting finding of 
this study was the negative seroconversion of those who tested positive during the 
first survey. Similar findings were reported by Ahmed (2008). The negative 
seroconversion could be due to parasite clearance by those individuals mostly 
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mediated by innate immune responses. Analysis of the innate immunity of those 
individuals might explain the mechanism of negative seroconversion. In this study 
about 25.8% of positive DAT participants remained positive through the second 
survey (with variation in the titer of some of them), those participants seemed to 
be continuously exposed to the parasite and remain subclinical or asymptomatic 
without developing clinical VL during the follow up. Similar finding was reported 
by Zijlstra et al, (1998), who found only 6 out of 12 subclinical subjects remained 
positive after 12 months follow up.  
Furthermore similar were reported by Silva et al (2011) in Brazil who found that 
46% subjects from endemic area had serological test positive result they had 
clinical reassessment 3–4 years after the first evaluation and revealed none of the 
subjects who tested positive developed clinical VL .The significant titer positive 
rate of anti-leishmania IgG compared to the lower rate of IgM indicates prolonged 
exposure to leishmania parasites. A similar high rate of IgG was previously 
reported by Ibrahim et al (1999). 
In this study prevalence of the serconverted participants ranged from 19.35%- 
29%, similar findings were reported by Silva et al (2011) in study conducted in 
Brazil using ELISArk26. The increase in anti-leishmania IgG subclass detected in 
the second survey could be used as prognosis marker based on the finding of 
Hailu et al (2001). Who followed individuals with positive anti-leishmania IgG 
and later developed clinical VL. 
The increase in anti-leishmania IgG2 antibody has been shown to be associated 
with asymptomatic infection (Almeda et al, 2005). Interestingly there was an 
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increase in both IgG3 and IgG4 indicating mixed Th1and Th2 response of 
exposed individuals. 
This study failed to detect circulating parasite DNA using PCR. This finding was 
expected since the participants were apparently healthy and the parasite load was 
either low or the parasite might had been cleared. The detected antibodies classes 
and subclasses reflect exposure of the participants and the follow was needed to 
detecting the long term impact on protection and susceptibility to clinical VL. 
This study had limitation regarding the sample size as well as loss of some 
participants during the follow up. The period of follow up needed to be extended 
to determine the outcome of the infection. 
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